Invention Application
- Patent Title: PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION
-
Application No.: US17882708Application Date: 2022-08-08
-
Publication No.: US20220387636A1Publication Date: 2022-12-08
- Inventor: Koichi FUKASE , Atsushi SHINOHARA , Yoshikatsu KANAI , Kazuya KABAYAMA , Kazuko KANEDA , Zijian ZHANG , Jun HATAZAWA , Yoshifumi SHIRAKAMI , Atsushi SHIMOYAMA , Yoshiyuki MANABE
- Applicant: OSAKA UNIVERSITY
- Applicant Address: JP Osaka
- Assignee: OSAKA UNIVERSITY
- Current Assignee: OSAKA UNIVERSITY
- Current Assignee Address: JP Osaka
- Priority: JP2018-048562 20180315
- Main IPC: A61K51/04
- IPC: A61K51/04
Abstract:
To develop a compound which is highly accumulated in cancer cells and capable of emitting an α-ray and provide a pharmaceutical composition for cancer treatment including the compound.
A pharmaceutical composition for cancer treatment including a compound having a structure in which 211At is introduced as a substituent into an amino acid derivative having an affinity with an amino acid transporter LAT1 or a pharmaceutically acceptable salt of the compound.
A pharmaceutical composition for cancer treatment including a compound having a structure in which 211At is introduced as a substituent into an amino acid derivative having an affinity with an amino acid transporter LAT1 or a pharmaceutically acceptable salt of the compound.
Information query
